Transcarent To Acquire Accolade (ACCD) for $7.03 per share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/17/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Appleās first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
- Yorkville Ives: 'GameStop Is Becoming the Hobby's Intake Network'
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Micron Technology stock drops on China chip news and labor dispute
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
- Truist Financial to sell $7.7B LightStream loan portfolio to Carlyle
Transcarent To Acquire Accolade
January 8, 2025 8:30 AM ESTCombined company creates industry leading platform with more than 1,400 employer and payer clients, with shared focus on consumer empowerment
Transcarents Generative AI WayFinding and care experiences combined with Accolades Advocacy, Expert Medical Opinion, and Primary Care will deliver on the promise of One Place for Health and Care
Accolade shareholders to receive $7.03 per share in cash
SAN FRANCISCO and SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Transcarent, the One Place for Health and Care, and Accolade (NASDAQ: ACCD), a leader in health... More



